Ichanexic acidCAS# 1044818-57-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 1044818-57-6 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C26H32O11 | M.Wt | 520.58 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Ichanexic acid Dilution Calculator
Ichanexic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9209 mL | 9.6047 mL | 19.2093 mL | 38.4187 mL | 48.0234 mL |
| 5 mM | 0.3842 mL | 1.9209 mL | 3.8419 mL | 7.6837 mL | 9.6047 mL |
| 10 mM | 0.1921 mL | 0.9605 mL | 1.9209 mL | 3.8419 mL | 4.8023 mL |
| 50 mM | 0.0384 mL | 0.1921 mL | 0.3842 mL | 0.7684 mL | 0.9605 mL |
| 100 mM | 0.0192 mL | 0.096 mL | 0.1921 mL | 0.3842 mL | 0.4802 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Disporopsin 4'-methyl ether
Catalog No.:BCX0402
CAS No.:1671098-53-5
- 8-Methyl-2'-deoxydisporopsin
Catalog No.:BCX0401
CAS No.:1671098-52-4
- 8-Methyldisporopsin 4'-methyl ether
Catalog No.:BCX0400
CAS No.:1589545-88-9
- 8-Methyldisporopsin
Catalog No.:BCX0399
CAS No.:1671098-51-3
- Disporopsin
Catalog No.:BCX0398
CAS No.:1430334-05-6
- 6-Aminoquinolyl-N-hydroxysuccinimidyl carbamate
Catalog No.:BCX0397
CAS No.:148757-94-2
- 17α-Deacetyltanghinin
Catalog No.:BCX0396
CAS No.:111614-46-1
- Levulinic acid
Catalog No.:BCX0395
CAS No.:123-76-2
- 4''-O-Glucosyl-17α-deacetyltanghinin
Catalog No.:BCX0394
CAS No.:114612-75-8
- Tetrahydrorhombifoline
Catalog No.:BCX0393
CAS No.:3382-84-1
- n-Butyl α-D-fructofuranoside
Catalog No.:BCX0392
CAS No.:80971-59-1
- Excoecafolin C
Catalog No.:BCX0391
CAS No.:1643370-00-6
- 3''-Methoxycentrolobol
Catalog No.:BCX0404
CAS No.:811471-19-9
- Kaempferol 7-O-(4''-O-methyl)glucoside
Catalog No.:BCX0405
CAS No.:1092795-48-6
- Suberanilic acid
Catalog No.:BCX0406
CAS No.:149648-52-2
- N1-Phenylsuberamide
Catalog No.:BCX0407
CAS No.:1305124-48-4
- Andrographidine G
Catalog No.:BCX0408
CAS No.:1494685-00-5
- Bisandrographolide G
Catalog No.:BCX0409
CAS No.:2699680-69-6
- Diplacol
Catalog No.:BCX0410
CAS No.:76556-05-3
- 4''-O-Glucosyl-17β-deacetyltanghinin
Catalog No.:BCX0411
CAS No.:114613-60-4
- 6''-O-(3-Hydroxy-3-methylglutaroyl)astragalin
Catalog No.:BCX0412
CAS No.:157407-84-6
- 12α-Methoxyabietic acid
Catalog No.:BCX0413
CAS No.:83905-80-0
- 4-(5-Oxotetrahydrofuran-2-yl)-N-phenylbutanamide
Catalog No.:BCX0414
CAS No.:100718-44-3
- (S)-5-Hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)heptan-3-one
Catalog No.:BCX0415
CAS No.:619297-56-2
Novel triterpenoid from Citrus aurantium L. possesses chemopreventive properties against human colon cancer cells.[Pubmed:18490169]
Bioorg Med Chem. 2008 Jun 1;16(11):5939-51.
Potential cancer preventive constituents of sour orange (Citrus aurantium L.) were isolated and identified from EtOAc extract of sour orange. Crude EtOAc extract was purified using silica gel column chromatography to isolate two putative bioactive compounds. The purity of the isolated compounds was analyzed by TLC and HPLC. The structures of the two compounds were identified by one-dimensional ((1)H, (13)C) and two-dimensional ((1)H-H and (1)H-(13)C) NMR experiments as isolimonic acid and a novel compound named as Ichanexic acid. Stereochemical assignment of the protons for both the compounds was made using one-dimensional nuclear Overhauser enhancement (nOe) experiments. The identified compounds were tested for the inhibition of human colon cancer cells (HT-29) proliferation, apoptosis, and on non-cancerous (COS-1 fibroblast) cells. Cell proliferation, arrest of cell growth, and induction of apoptosis were determined by MTT assay, flow cytometry, and nuclear staining methods, respectively. The MTT assay indicated that both the compounds exhibited differential inhibition at various concentrations. Significant arrest of cell growth by isolimonoic acid was noticed within 24h of treatment on the HT-29 colon cancer cells at a concentration as low as 5.0microM (P=0.005) and by Ichanexic acid at 10.0microM (P=0.011). None of the compounds exerted any apparent cytostatic effects on the non-cancerous COS-1 fibroblast cells. Both the compounds exerted nearly 4- to 5-fold increase in the counts of G2/M stage cells at 5microM indicating a potential role in the cell cycle arrest as well as possible lead structures for the development of cancer chemopreventive and therapeutic agents. To the best of our knowledge, this is the first report on isolation, identification of isolimonic acid in its native form, and compound 2 was found to a novel and identified as Ichanexic acid.
